Silvetti Massimo Stefano, De Santis Antonella, Grovale Nicoletta, Grutter Giorgia, Baccarini Andrea, Drago Fabrizio
Pediatric Cardiology Department, Ospedale Bambino Gesù, Roma, Italy.
Pacing Clin Electrophysiol. 2007 Feb;30(2):175-81. doi: 10.1111/j.1540-8159.2007.00646.x.
Ventricular Capture Management (VCM) is a Medtronic Kappa pacemakers (PM) feature that automatically measures pacing threshold through detection of the evoked response after a pacing stimulus. The aim of this study was to evaluate the range of variation of ventricular pacing threshold in pediatric patients with endocardial and epicardial pacing leads. Thirty-one patients (median age 6.5 years) were implanted with a Kappa 901 PM for atrioventricular block or sinus node dysfunction. Congenital heart defects (CHD) were present in 58% of patients. Ventricular leads were epicardial in 52% of patients. VCM was programmed to automatically measure threshold every 2 hours. In a median follow-up of 12 months, 27,110 threshold measurements, 72% of which were successful, have been taken in 94% of patients. Measurement success was 99% in the endocardial leads group (age at implantation 12 +/- 6 years) and 31% in epicardial leads (age 4 +/- 5 years) (P < 0.05). Main reasons for unsuccessful measurements were high heart rate and, in a patient with an endocardial lead, competition with intrinsic rhythm. Undersensing or oversensing of the evoked responses was not detected. In all successful VCM measurements, epicardial pacing and CHD contributed to stability of thresholds (multivariate analysis). Pacing threshold showed specific circadian patterns: higher thresholds were found between 00.00 and 06.00 a.m., but the variation was low, 0.03 +/- 0.01 V. In conclusion, children and young patients show stable ventricular thresholds, especially in presence of CHD, and epicardial leads are at least as stable as endocardial leads. Ventricular pacing threshold showed a circadian variability similar to that described in adults, that does not seem to influence VCM functioning and PM programming.
心室夺获管理(VCM)是美敦力Kappa起搏器(PM)的一项功能,可通过检测起搏刺激后的诱发反应自动测量起搏阈值。本研究的目的是评估采用心内膜和心外膜起搏导线的儿科患者心室起搏阈值的变化范围。31例患者(中位年龄6.5岁)植入Kappa 901 PM用于治疗房室传导阻滞或窦房结功能障碍。58%的患者存在先天性心脏病(CHD)。52%的患者采用心外膜心室导线。VCM被设定为每2小时自动测量一次阈值。在中位随访12个月期间,94%的患者进行了27110次阈值测量,其中72%测量成功。心内膜导线组(植入时年龄12±6岁)测量成功率为99%,心外膜导线组(年龄4±5岁)为31%(P<0.05)。测量失败的主要原因是心率过快,以及1例心内膜导线患者存在与自身节律的竞争。未检测到诱发反应的感知不足或感知过度。在所有成功的VCM测量中,心外膜起搏和CHD有助于阈值的稳定性(多变量分析)。起搏阈值呈现特定的昼夜模式:凌晨00:00至06:00之间阈值较高,但变化较小,为0.03±0.01V。总之,儿童和年轻患者的心室阈值稳定,尤其是存在CHD时,心外膜导线至少与心内膜导线一样稳定。心室起搏阈值呈现与成人相似的昼夜变异性,这似乎不影响VCM功能和PM编程。